Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. PAVmed Inc.
  6. News
  7. Summary
    PAVM   US70387R1068

PAVMED INC.

(PAVM)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

PAVmed Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021

11/22/2021 | 05:28pm EST

PAVmed Inc. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was USD 0.2 million. Net loss was USD 12.23 million compared to USD 5.48 million a year ago. Basic loss per share from continuing operations was USD 0.15 compared to USD 0.11 a year ago. For the nine months, sales was USD 0.2 million. Net loss was USD 33.13 million compared to USD 25.54 million a year ago. Basic loss per share from continuing operations was USD 0.42 compared to USD 0.57 a year ago.


ę S&P Capital IQ 2021
All news about PAVMED INC.
01/12PAVmed Inc. and Lucid Diagnostics Inc. Appoint D.A. Wallace as Director, Retail Investo..
CI
01/06Lucid Diagnostics to Participate in a Fireside Chat at the 24th Annual Needham Virtual ..
BU
2021PAVmed Files $275 Million Mixed Shelf -- Shares Sink
MT
2021Health Care Stocks Retreat Pre-Bell Wednesday
MT
2021PAVmed Files $275 Million Mixed Shelf
MT
2021PAVMED INC.(NASDAQCM : PAVM) dropped from S&P Healthcare Equipment Select Industry Index
CI
2021PAVmed Subsidiary Lucid Diagnostics Launches EsoGuard Telemedicine Program in Partnersh..
BU
2021PAVMED INC. Management's Discussion and Analysis of Financial Condition and Results of..
AQ
2021PAVmed Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended Septem..
CI
2021Health Care Stocks Manage Modest Gains Wednesday
MT
More news
Analyst Recommendations on PAVMED INC.
More recommendations
Financials (USD)
Sales 2021 0,68 M - -
Net income 2021 -47,3 M - -
Net cash 2021 49,0 M - -
P/E ratio 2021 -2,84x
Yield 2021 -
Capitalization 146 M 146 M -
EV / Sales 2021 142x
EV / Sales 2022 11,9x
Nbr of Employees 25
Free-Float 89,5%
Chart PAVMED INC.
Duration : Period :
PAVmed Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PAVMED INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 1,66 $
Average target price 10,13 $
Spread / Average Target 510%
EPS Revisions
Managers and Directors
Lishan Aklog Chairman & Chief Executive Officer
Dennis M. McGrath President, Chief Financial Officer & Secretary
Brian J. deGuzman Chief Medical Officer & Executive Vice President
Michael J. Glennon Vice Chairman
Ronald M. Sparks Independent Director
Sector and Competitors
1st jan.Capi. (M$)
PAVMED INC.-32.52%146
THERMO FISHER SCIENTIFIC-11.85%231 763
DANAHER CORPORATION-14.00%202 197
INTUITIVE SURGICAL, INC.-18.53%104 574
SIEMENS HEALTHINEERS AG-6.05%78 653
EDWARDS LIFESCIENCES CORPORATION-10.80%72 148